These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. dos Santos DM; Talvani A; Guedes PM; Machado-Coelho GL; de Lana M; Bahia MT Exp Parasitol; 2009 Jan; 121(1):8-14. PubMed ID: 18848935 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole. Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149 [TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice. Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321 [TBL] [Abstract][Full Text] [Related]
25. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens]. Moretti E; Cervetta L; Basso B; Castro I; Santamarina N Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716 [TBL] [Abstract][Full Text] [Related]
26. [Part VI. Antiparasitic treatment for Chagas disease]. B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153 [TBL] [Abstract][Full Text] [Related]
27. Rural Triatoma rubrovaria from southern Brazil harbors Trypanosoma cruzi of lineage IIc. Martins LP; Marcili A; Castanho RE; Therezo AL; de Oliveira JC; Suzuki RB; Teixeira MM; da Rosa JA; Sperança MA Am J Trop Med Hyg; 2008 Sep; 79(3):427-34. PubMed ID: 18784237 [TBL] [Abstract][Full Text] [Related]
28. DNA damage and nitric oxide synthesis in experimentally infected Balb/c mice with Trypanosoma cruzi. Ribeiro DA; Calvi SA; Picka MM; Persi E; de Carvalho TB; Caetano PK; Nagoshi LR; Lima CR; Machado JM; Salvadori DM Exp Parasitol; 2007 Jul; 116(3):296-301. PubMed ID: 17286971 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of Chagas' disease]. Apt W Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147 [No Abstract] [Full Text] [Related]
30. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi. Amuchástegui PI; Moretti ER; Basso B; Sperandeo N; de Bertorello MM Rev Argent Microbiol; 1990; 22(4):199-207. PubMed ID: 2129475 [TBL] [Abstract][Full Text] [Related]
32. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy. Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370 [TBL] [Abstract][Full Text] [Related]
33. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities. Boechat N; Carvalho AS; Fernandez-Ferreira E; Soares RO; Souza AS; Gibaldi D; Bozza M; Pinto AC Cytobios; 2001; 105(409):83-90. PubMed ID: 11393774 [TBL] [Abstract][Full Text] [Related]
34. [Experimental and preliminary observation on the ultimate influence of cyclosporin on chronic infection of mice by Trypanosoma cruzi]. Amato Neto V; Moreira AA; Campos R; Duarte MI; Pinto PL; de Sant'Ana EJ Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):219-21. PubMed ID: 3108993 [No Abstract] [Full Text] [Related]
35. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. Toledo MJ; Bahia MT; Veloso VM; Carneiro CM; Machado-Coelho GL; Alves CF; Martins HR; Cruz RE; Tafuri WL; Lana M J Antimicrob Chemother; 2004 Jun; 53(6):1045-53. PubMed ID: 15102747 [TBL] [Abstract][Full Text] [Related]
36. The activity of nifluridide on reduviids and rodent and human trypanosomes. Dusanic DG; Boisvenue RJ Z Parasitenkd; 1982; 68(2):155-60. PubMed ID: 6815915 [TBL] [Abstract][Full Text] [Related]
37. Differences in the susceptibility of Trypanosoma cruzi strains to active chemotherapeutic agents. Brener Z; Costa CA; Chiari C Rev Inst Med Trop Sao Paulo; 1976; 18(6):450-5. PubMed ID: 828295 [No Abstract] [Full Text] [Related]
38. [Evaluation of antiparasitic activity of allopurinol, against Trypanosoma cruzi, in experimental system using infected triatomines]. Carignani FL; Braz LM; Neto VA; de Souza ER Rev Soc Bras Med Trop; 2000; 33(6):613-5. PubMed ID: 11175595 [TBL] [Abstract][Full Text] [Related]
39. [Experimental study on the resistance of a strain of Trypanosoma cruzi to Bay 2502]. Andrade SG; Andrade ZA; Figueira RM Rev Inst Med Trop Sao Paulo; 1977; 19(2):124-9. PubMed ID: 408896 [No Abstract] [Full Text] [Related]
40. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice. Murray PK; Habbersett MC; Meurer RD Am J Trop Med Hyg; 1983 Nov; 32(6):1242-50. PubMed ID: 6418014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]